AU2003214023A1 - Dimeric tf antagonist comprising two factor vii polypeptides - Google Patents
Dimeric tf antagonist comprising two factor vii polypeptidesInfo
- Publication number
- AU2003214023A1 AU2003214023A1 AU2003214023A AU2003214023A AU2003214023A1 AU 2003214023 A1 AU2003214023 A1 AU 2003214023A1 AU 2003214023 A AU2003214023 A AU 2003214023A AU 2003214023 A AU2003214023 A AU 2003214023A AU 2003214023 A1 AU2003214023 A1 AU 2003214023A1
- Authority
- AU
- Australia
- Prior art keywords
- dimeric
- antagonist
- factor vii
- vii polypeptides
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200200373 | 2002-03-12 | ||
DKPA200200373 | 2002-03-12 | ||
PCT/DK2003/000151 WO2003076461A2 (en) | 2002-03-12 | 2003-03-12 | Dimeric tf antagonist comprising two factor vii polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003214023A8 AU2003214023A8 (en) | 2003-09-22 |
AU2003214023A1 true AU2003214023A1 (en) | 2003-09-22 |
Family
ID=27798725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003214023A Abandoned AU2003214023A1 (en) | 2002-03-12 | 2003-03-12 | Dimeric tf antagonist comprising two factor vii polypeptides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1485476A2 (en) |
JP (1) | JP2005538936A (en) |
AU (1) | AU2003214023A1 (en) |
WO (1) | WO2003076461A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20060426A1 (en) * | 2004-06-02 | 2006-06-28 | Schering Corp | TARTARIC ACID DERIVATIVES AS INHIBITORS OF MMPs, ADAMs, TACE AND TNF-alpha |
US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
ES2434032T3 (en) * | 2005-06-17 | 2013-12-13 | Novo Nordisk Health Care Ag | Dimeric and multimeric FVIIA compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932448A (en) * | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
DK132892D0 (en) * | 1992-10-30 | 1992-10-30 | Novo Nordisk As | PROTEINS |
ATE173630T1 (en) * | 1992-12-29 | 1998-12-15 | Genentech Inc | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH INTERFERON-GAMMA INHIBITORS |
US5736364A (en) * | 1995-12-04 | 1998-04-07 | Genentech, Inc. | Factor viia inhibitors |
DK1198479T3 (en) * | 1999-07-01 | 2008-10-13 | Univ Yale | Neovascular-targeted immune conjugate |
AU7270600A (en) * | 1999-09-20 | 2001-04-24 | Novo Nordisk A/S | Bivalent inhibitor of fviia/tf/fxa complex |
US6423826B1 (en) * | 2000-06-30 | 2002-07-23 | Regents Of The University Of Minnesota | High molecular weight derivatives of vitamin K-dependent polypeptides |
-
2003
- 2003-03-12 AU AU2003214023A patent/AU2003214023A1/en not_active Abandoned
- 2003-03-12 WO PCT/DK2003/000151 patent/WO2003076461A2/en not_active Application Discontinuation
- 2003-03-12 JP JP2003574676A patent/JP2005538936A/en not_active Withdrawn
- 2003-03-12 EP EP03709668A patent/EP1485476A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2003214023A8 (en) | 2003-09-22 |
WO2003076461A2 (en) | 2003-09-18 |
JP2005538936A (en) | 2005-12-22 |
EP1485476A2 (en) | 2004-12-15 |
WO2003076461A3 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002341834A1 (en) | Antagonists | |
AU2003243436A1 (en) | Reconstituted polypeptides | |
WO2004020186A9 (en) | Indefinite materials | |
AU2003235493A1 (en) | Multifunctional polypeptides | |
IL165841A0 (en) | Mchir antagonists | |
GB0208331D0 (en) | Proteins | |
GB0209884D0 (en) | Proteins | |
AU2003291959A1 (en) | Novel glucagon antagonists | |
AU2003281890A1 (en) | Height-adjustable discharge slider | |
AU2003285586A1 (en) | Regulatory t-cells | |
AU2003258028A1 (en) | Multi-layer softball | |
AU2003242506A1 (en) | Tf antagonist | |
AU2002241899A1 (en) | Tip39 polypeptides | |
GB0218977D0 (en) | Polypeptide | |
EP1487874A4 (en) | Falp proteins | |
AU2003214023A1 (en) | Dimeric tf antagonist comprising two factor vii polypeptides | |
GB0200689D0 (en) | Fusion proteins | |
AU2003212294A1 (en) | Seam arrangement | |
GB0223193D0 (en) | Polypeptide | |
PL375202A1 (en) | Cytokine polypeptides | |
AU2003270055A8 (en) | Neurotransmission-associated proteins | |
GB0208925D0 (en) | Polypeptide | |
AU2003300785A8 (en) | Carbohydrate-associated proteins | |
AU2002100902A4 (en) | Counterbalanced barrier | |
GB0202822D0 (en) | Butt only rodrest |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |